ArticleNature cancer2024

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.

Meenakshi Hegde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.